Weiss Ratings Reaffirms "Buy (B)" Rating for Omega Healthcare Investors (NYSE:OHI)

Key Points

• Weiss Ratings has reaffirmed a "Buy (B)" rating for Omega Healthcare Investors (NYSE: OHI), indicating positive sentiment toward the stock.
• Seven analysts currently rate the stock as a Buy, with a consensus target price of $44.44 and a recent uplift in price targets from firms including Wells Fargo and Scotiabank.
• Omega Healthcare reported earnings of $0.77 per share, surpassing estimates by $0.32, and is projected to post an EPS of 2.86 for the current year.

Omega Healthcare Investors (NYSE:OHI - Get Free Report)'s stock had its "buy (b)" rating reissued by stock analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

OHI has been the topic of a number of other reports. Wells Fargo & Company lifted their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a report on Thursday, August 28th. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Royal Bank Of Canada lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Finally, Mizuho lifted their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday, September 11th. Seven equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $44.44.

Omega Healthcare Investors Stock Down 0.2%

OHI traded down $0.09 during trading on Wednesday, reaching $40.59. The company had a trading volume of 39,270 shares, compared to its average volume of 2,280,615. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors has a 12 month low of $35.04 and a 12 month high of $44.42. The business's fifty day moving average price is $41.55 and its 200 day moving average price is $38.77. The company has a market cap of $11.97 billion, a P/E ratio of 25.05, a PEG ratio of 1.91 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. During the same quarter in the previous year, the firm posted $0.71 earnings per share. The business's revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities analysts anticipate that Omega Healthcare Investors will post 2.86 EPS for the current year.

Insiders Place Their Bets

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd acquired a new position in shares of Omega Healthcare Investors in the second quarter valued at $26,000. NBC Securities Inc. acquired a new position in shares of Omega Healthcare Investors in the first quarter valued at $29,000. Salem Investment Counselors Inc. acquired a new position in shares of Omega Healthcare Investors in the third quarter valued at $39,000. Smartleaf Asset Management LLC increased its holdings in shares of Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock valued at $34,000 after purchasing an additional 268 shares during the last quarter. Finally, CENTRAL TRUST Co increased its holdings in shares of Omega Healthcare Investors by 1,654.4% in the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 943 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.